Conning Inc. Biogen Inc. Transaction History

Conning Inc.

$2.89 Billion
Q3 2024

A detailed history of Conning Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Conning Inc. holds 1,066 shares of BIIB stock, worth $156,137. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,066

Previous 1,073 0.65%

Holding current value

$156,137

Previous $248,000 16.94%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$189.07 - $236.8 $1,323 - $1,657	-7 Reduced 0.65%	1,066 $206,000
Q4 2023 Jan 29, 2024	BUY	$222.59 - $267.94 $3,338 - $4,019	15 Added 1.42%	1,073 $277,000
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $6,332 - $7,147	-25 Reduced 2.31%	1,058 $271,000
Q2 2023 Jul 21, 2023	SELL	$275.25 - $318.06 $31,653 - $36,576	-115 Reduced 9.6%	1,083 $308,000
Q1 2023 Apr 27, 2023	SELL	$256.56 - $292.34 $2,565 - $2,923	-10 Reduced 0.83%	1,198 $333,000
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $1,009 - $1,226	-4 Reduced 0.33%	1,208 $334,000
Q3 2022 Oct 28, 2022	SELL	$194.69 - $268.46 $24,141 - $33,289	-124 Reduced 9.28%	1,212 $324,000
Q2 2022 Jul 20, 2022	SELL	$187.54 - $223.02 $750 - $892	-4 Reduced 0.3%	1,336 $272,000
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $50,380 - $63,476	-260 Reduced 16.25%	1,340 $282,000
Q4 2021 Jan 27, 2022	SELL	$223.92 - $287.77 $34,931 - $44,892	-156 Reduced 8.88%	1,600 $384,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $295,158 - $384,919	-1,043 Reduced 37.26%	1,756 $497,000
Q2 2021 Jul 29, 2021	SELL	$259.0 - $414.71 $45,843 - $73,403	-177 Reduced 5.95%	2,799 $969,000
Q1 2021 Apr 23, 2021	SELL	$242.95 - $284.63 $48,590 - $56,926	-200 Reduced 6.3%	2,976 $833,000
Q4 2020 Jan 28, 2021	SELL	$236.26 - $355.63 $88,597 - $133,361	-375 Reduced 10.56%	3,176 $778,000
Q3 2020 Oct 21, 2020	SELL	$264.77 - $305.71 $11,914 - $13,756	-45 Reduced 1.25%	3,551 $1.01 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $71,648 - $94,886	-277 Reduced 7.15%	3,596 $962,000
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $27,422 - $34,786	-102 Reduced 2.57%	3,873 $1.23 Million
Q4 2019 Jan 29, 2020	BUY	$220.06 - $304.07 $147,440 - $203,726	670 Added 20.27%	3,975 $1.18 Million
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $17,395 - $19,510	-80 Reduced 2.36%	3,305 $769,000
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $456,561 - $503,261	-2,082 Reduced 38.08%	3,385 $792,000
Q1 2019 Apr 22, 2019	SELL	$216.71 - $338.96 $13,002 - $20,337	-60 Reduced 1.09%	5,467 $1.29 Million
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $139,250 - $176,375	-500 Reduced 8.3%	5,527 $1.66 Million
Q3 2018 Oct 26, 2018	SELL	$293.51 - $383.83 $127,383 - $166,582	-434 Reduced 6.72%	6,027 $2.13 Million
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $30,902 - $36,829	-120 Reduced 1.82%	6,461 $1.88 Million
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $33,816 - $47,828	-130 Reduced 1.94%	6,581 $1.8 Million
Q4 2017 Jan 30, 2018	SELL	$307.64 - $344.58 $24,611 - $27,566	-80 Reduced 1.18%	6,711 $2.14 Million
Q3 2017 Oct 20, 2017	BUY	$281.15 - $329.69 $1.91 Million - $2.24 Million	6,791	6,791 $2.13 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account